1. Home
  2. BARK vs ACET Comparison

BARK vs ACET Comparison

Compare BARK & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BARK Inc.

BARK

BARK Inc.

HOLD

Current Price

$9.06

Market Cap

92.7M

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$9.11

Market Cap

79.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BARK
ACET
Founded
2011
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.7M
79.9M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
BARK
ACET
Price
$9.06
$9.11
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$37.50
$48.33
AVG Volume (30 Days)
35.3K
83.5K
Earning Date
06-03-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.43
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.46
52 Week High
$11.00
$9.47

Technical Indicators

Market Signals
Indicator
BARK
ACET
Relative Strength Index (RSI) 47.97 53.51
Support Level $9.04 $7.78
Resistance Level $9.86 $8.68
Average True Range (ATR) 0.36 0.53
MACD -0.04 0.02
Stochastic Oscillator 43.84 65.96

Price Performance

Historical Comparison
BARK
ACET

About BARK BARK Inc.

BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Share on Social Networks: